Delivery Order SPE2DB22D2007-SPE2DB25FJ3QX
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package, with a ceiling value of $4,539.09 and a completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. Ondansetron is an antiemetic...
- The Defense Logistics Agency awarded a delivery order valued at $2,834.30 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-competitive, firm fixed-price delivery order was executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $4,566.42 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT (orally disintegrating tablet) 8 mg in quantities of 30 tablets. The contract is a firm fixed price delivery order with an ultimate completion date of September 19, 2025, and was awarded on September 18, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the Conshohocken,...
- The Defense Logistics Agency awarded a $10,330.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $17,662.48 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count package) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $13,399.76 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. Ondansetron is an antiemetic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) valued at $3,534.12. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is scheduled for completion by April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely-used...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-tablet configuration. This firm fixed-price delivery order carries a ceiling value of $2,606.12 and is scheduled for completion by August 12, 2025. The contract was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,854.40 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ondansetron ODT 8mg in a quantity of 30 units. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used to prevent nausea and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $11,260.46 under a firm fixed price contract type. The award, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...